In 2016, cancer biologist Johanna Joyce of the Memorial Sloan Kettering Cancer Center published a study in Science that ...

A spin-out from the University of Edinburgh in Scotland is already equipped with 15 million pounds ($19 million) in seed ...

Glioblastoma is the most common kind of malignant brain tumor in adults. So far, no treatment has been able to make this ...

Immunotherapy, which enhances the immune system's T cell response to eliminate cancer cells, has emerged as a key approach in ...

Filippo Veglia, Ph.D., of Wistar’s Genome Regulation and Cell Signaling Program, discusses the most lethal form of brain cancer.

Trials with mice in whom the researchers implanted human glioblastoma cells have already shown that the treatment is very ...

Even treated with the most advanced therapies, patients with glioblastoma—an aggressive brain cancer—typically survive less ...

Researchers have identified potential drug targets in glioblastoma cancer stem cells, providing a new approach to treat this ...

Glioblastoma is the most common kind of malignant brain tumor in adults. So far, no treatment has been able to make this ...

Researchers have developed an innovative CAR T-cell therapy to combat glioblastoma, the most common malignant brain tumor in ...

Newly discovered targets may hold the key to effectively treating glioblastoma, a deadly form of brain cancer. These targets ...

Company also names Deancy Okoebor Director of Clinical Operations and Eva Highberg Schumann Project Coordinator as it ...